These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 36241648)
1. ARHGEF3 regulates the stability of ACLY to promote the proliferation of lung cancer. Zhou F; Ai W; Zhang Y; Hu Q; Gan M; Wang JB; Han T Cell Death Dis; 2022 Oct; 13(10):870. PubMed ID: 36241648 [TBL] [Abstract][Full Text] [Related]
2. ARHGEF3 controls HDACi-induced differentiation via RhoA-dependent pathways in acute myeloid leukemias. D'Amato L; Dell'Aversana C; Conte M; Ciotta A; Scisciola L; Carissimo A; Nebbioso A; Altucci L Epigenetics; 2015; 10(1):6-18. PubMed ID: 25494542 [TBL] [Abstract][Full Text] [Related]
4. Role of Rho guanine nucleotide exchange factors in non-small cell lung cancer. Zeng RJ; Xie WJ; Zheng CW; Chen WX; Wang SM; Li Z; Cheng CB; Zou HY; Xu LY; Li EM Bioengineered; 2021 Dec; 12(2):11169-11187. PubMed ID: 34783629 [TBL] [Abstract][Full Text] [Related]
5. The role of Mg2+ cofactor in the guanine nucleotide exchange and GTP hydrolysis reactions of Rho family GTP-binding proteins. Zhang B; Zhang Y; Wang Z; Zheng Y J Biol Chem; 2000 Aug; 275(33):25299-307. PubMed ID: 10843989 [TBL] [Abstract][Full Text] [Related]
6. Rho GEFs and GAPs: emerging integrators of extracellular matrix signaling. Kutys ML; Yamada KM Small GTPases; 2015; 6(1):16-9. PubMed ID: 25862162 [TBL] [Abstract][Full Text] [Related]
7. Role of ARHGEF3 as a GEF and mTORC2 Regulator. Khaliq SA; Umair Z; Yoon MS Front Cell Dev Biol; 2021; 9():806258. PubMed ID: 35174167 [TBL] [Abstract][Full Text] [Related]